On Monday, Roivant Sciences Ltd (NASDAQ: ROIV) opened lower -1.54% from the last session, before settling in for the closing price of $11.69. Price fluctuations for ROIV have ranged from $9.69 to $13.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 493.24% over the past five years. Company’s average yearly earnings per share was noted -114.65% at the time writing. With a float of $376.90 million, this company’s outstanding shares have now reached $733.33 million.
Let’s look at the performance matrix of the company that is accounted for 908 employees. In terms of profitability, gross margin is 88.77%, operating margin of 3447.71%, and the pretax margin is 3781.64%.
Roivant Sciences Ltd (ROIV) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Roivant Sciences Ltd is 48.22%, while institutional ownership is 67.67%. The most recent insider transaction that took place on Dec 27 ’24, was worth 2,090,958. In this transaction President & COO of this company sold 176,900 shares at a rate of $11.82, taking the stock ownership to the 668,680 shares. Before that another transaction happened on Dec 30 ’24, when Company’s President & COO sold 177,704 for $11.54, making the entire transaction worth $2,050,704. This insider now owns 740,976 shares in total.
Roivant Sciences Ltd (ROIV) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -114.65% per share during the next fiscal year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
Check out the current performance indicators for Roivant Sciences Ltd (ROIV). In the past quarter, the stock posted a quick ratio of 10.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 64.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.66, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -1.09 in one year’s time.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Roivant Sciences Ltd (NASDAQ: ROIV) saw its 5-day average volume 4.16 million, a negative change from its year-to-date volume of 4.17 million. As of the previous 9 days, the stock’s Stochastic %D was 46.99%. Additionally, its Average True Range was 0.34.
During the past 100 days, Roivant Sciences Ltd’s (ROIV) raw stochastic average was set at 23.13%, which indicates a significant increase from 16.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.02% in the past 14 days, which was higher than the 28.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.89, while its 200-day Moving Average is $11.36. Nevertheless, the first resistance level for the watch stands at $11.69 in the near term. At $11.87, the stock is likely to face the second major resistance level. The third major resistance level sits at $11.98. If the price goes on to break the first support level at $11.39, it is likely to go to the next support level at $11.28. Assuming the price breaks the second support level, the third support level stands at $11.10.
Roivant Sciences Ltd (NASDAQ: ROIV) Key Stats
There are currently 727,950K shares outstanding in the company with a market cap of 8.11 billion. Presently, the company’s annual sales total 124,800 K according to its annual income of 4,349 M. Last quarter, the company’s sales amounted to 4,480 K and its income totaled -230,180 K.
